Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy

Standard

Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy. / Bartosova, Maria; Schaefer, Betti; Bermejo, Justo Lorenzo; Tarantino, Silvia; Lasitschka, Felix; Macher-Goeppinger, Stephan; Sinn, Peter; Warady, Bradley A; Zaloszyc, Ariane; Parapatics, Katja; Májek, Peter; Bennett, Keiryn L; Oh, Jun; Aufricht, Christoph; Schaefer, Franz; Kratochwill, Klaus; Schmitt, Claus Peter.

In: J AM SOC NEPHROL, 18.10.2017.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Bartosova, M, Schaefer, B, Bermejo, JL, Tarantino, S, Lasitschka, F, Macher-Goeppinger, S, Sinn, P, Warady, BA, Zaloszyc, A, Parapatics, K, Májek, P, Bennett, KL, Oh, J, Aufricht, C, Schaefer, F, Kratochwill, K & Schmitt, CP 2017, 'Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy', J AM SOC NEPHROL. https://doi.org/10.1681/ASN.2017040436

APA

Bartosova, M., Schaefer, B., Bermejo, J. L., Tarantino, S., Lasitschka, F., Macher-Goeppinger, S., Sinn, P., Warady, B. A., Zaloszyc, A., Parapatics, K., Májek, P., Bennett, K. L., Oh, J., Aufricht, C., Schaefer, F., Kratochwill, K., & Schmitt, C. P. (2017). Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy. J AM SOC NEPHROL. https://doi.org/10.1681/ASN.2017040436

Vancouver

Bartosova M, Schaefer B, Bermejo JL, Tarantino S, Lasitschka F, Macher-Goeppinger S et al. Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy. J AM SOC NEPHROL. 2017 Oct 18. https://doi.org/10.1681/ASN.2017040436

Bibtex

@article{75887b1c76294f778269ef03f0dbab53,
title = "Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy",
abstract = "Cardiovascular disease (CVD) is the leading cause of increased mortality in patients with CKD and is further aggravated by peritoneal dialysis (PD). Children are devoid of preexisting CVD and provide unique insight into specific uremia- and PD-induced pathomechanisms of CVD. We obtained peritoneal specimens from children with stage 5 CKD at time of PD catheter insertion (CKD5 group), children with established PD (PD group), and age-matched nonuremic controls (n=6/group). We microdissected omental arterioles from tissue layers not directly exposed to PD fluid and used adjacent sections of four arterioles per patient for transcriptomic and proteomic analyses. Findings were validated in omental and parietal arterioles from independent pediatric control (n=5), CKD5 (n=15), and PD (n=15) cohorts. Transcriptomic analysis revealed differential gene expression in control versus CKD5 arterioles and in CKD5 versus PD arterioles. Gene ontology analyses revealed activation of metabolic processes in CKD5 arterioles and of inflammatory, immunologic, and stress-response cascades in PD arterioles. PD arterioles exhibited particular upregulation of the complement system and respective regulatory pathways, with concordant findings at the proteomic level. In the validation cohorts, PD specimens had the highest abundance of omental and parietal arteriolar C1q, C3d, terminal complement complex, and phosphorylated SMAD2/3, a downstream effector of TGF-β Furthermore, in the PD parietal arterioles, C1q and terminal complement complex abundance correlated with the level of dialytic glucose exposure, abundance of phosphorylated SMAD2/3, and degree of vasculopathy. We conclude that PD fluids activate arteriolar complement and TGF-β signaling, which quantitatively correlate with the severity of arteriolar vasculopathy.",
keywords = "Journal Article",
author = "Maria Bartosova and Betti Schaefer and Bermejo, {Justo Lorenzo} and Silvia Tarantino and Felix Lasitschka and Stephan Macher-Goeppinger and Peter Sinn and Warady, {Bradley A} and Ariane Zaloszyc and Katja Parapatics and Peter M{\'a}jek and Bennett, {Keiryn L} and Jun Oh and Christoph Aufricht and Franz Schaefer and Klaus Kratochwill and Schmitt, {Claus Peter}",
note = "Copyright {\textcopyright} 2017 by the American Society of Nephrology.",
year = "2017",
month = oct,
day = "18",
doi = "10.1681/ASN.2017040436",
language = "English",
journal = "J AM SOC NEPHROL",
issn = "1046-6673",
publisher = "American Society of Nephrology",

}

RIS

TY - JOUR

T1 - Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy

AU - Bartosova, Maria

AU - Schaefer, Betti

AU - Bermejo, Justo Lorenzo

AU - Tarantino, Silvia

AU - Lasitschka, Felix

AU - Macher-Goeppinger, Stephan

AU - Sinn, Peter

AU - Warady, Bradley A

AU - Zaloszyc, Ariane

AU - Parapatics, Katja

AU - Májek, Peter

AU - Bennett, Keiryn L

AU - Oh, Jun

AU - Aufricht, Christoph

AU - Schaefer, Franz

AU - Kratochwill, Klaus

AU - Schmitt, Claus Peter

N1 - Copyright © 2017 by the American Society of Nephrology.

PY - 2017/10/18

Y1 - 2017/10/18

N2 - Cardiovascular disease (CVD) is the leading cause of increased mortality in patients with CKD and is further aggravated by peritoneal dialysis (PD). Children are devoid of preexisting CVD and provide unique insight into specific uremia- and PD-induced pathomechanisms of CVD. We obtained peritoneal specimens from children with stage 5 CKD at time of PD catheter insertion (CKD5 group), children with established PD (PD group), and age-matched nonuremic controls (n=6/group). We microdissected omental arterioles from tissue layers not directly exposed to PD fluid and used adjacent sections of four arterioles per patient for transcriptomic and proteomic analyses. Findings were validated in omental and parietal arterioles from independent pediatric control (n=5), CKD5 (n=15), and PD (n=15) cohorts. Transcriptomic analysis revealed differential gene expression in control versus CKD5 arterioles and in CKD5 versus PD arterioles. Gene ontology analyses revealed activation of metabolic processes in CKD5 arterioles and of inflammatory, immunologic, and stress-response cascades in PD arterioles. PD arterioles exhibited particular upregulation of the complement system and respective regulatory pathways, with concordant findings at the proteomic level. In the validation cohorts, PD specimens had the highest abundance of omental and parietal arteriolar C1q, C3d, terminal complement complex, and phosphorylated SMAD2/3, a downstream effector of TGF-β Furthermore, in the PD parietal arterioles, C1q and terminal complement complex abundance correlated with the level of dialytic glucose exposure, abundance of phosphorylated SMAD2/3, and degree of vasculopathy. We conclude that PD fluids activate arteriolar complement and TGF-β signaling, which quantitatively correlate with the severity of arteriolar vasculopathy.

AB - Cardiovascular disease (CVD) is the leading cause of increased mortality in patients with CKD and is further aggravated by peritoneal dialysis (PD). Children are devoid of preexisting CVD and provide unique insight into specific uremia- and PD-induced pathomechanisms of CVD. We obtained peritoneal specimens from children with stage 5 CKD at time of PD catheter insertion (CKD5 group), children with established PD (PD group), and age-matched nonuremic controls (n=6/group). We microdissected omental arterioles from tissue layers not directly exposed to PD fluid and used adjacent sections of four arterioles per patient for transcriptomic and proteomic analyses. Findings were validated in omental and parietal arterioles from independent pediatric control (n=5), CKD5 (n=15), and PD (n=15) cohorts. Transcriptomic analysis revealed differential gene expression in control versus CKD5 arterioles and in CKD5 versus PD arterioles. Gene ontology analyses revealed activation of metabolic processes in CKD5 arterioles and of inflammatory, immunologic, and stress-response cascades in PD arterioles. PD arterioles exhibited particular upregulation of the complement system and respective regulatory pathways, with concordant findings at the proteomic level. In the validation cohorts, PD specimens had the highest abundance of omental and parietal arteriolar C1q, C3d, terminal complement complex, and phosphorylated SMAD2/3, a downstream effector of TGF-β Furthermore, in the PD parietal arterioles, C1q and terminal complement complex abundance correlated with the level of dialytic glucose exposure, abundance of phosphorylated SMAD2/3, and degree of vasculopathy. We conclude that PD fluids activate arteriolar complement and TGF-β signaling, which quantitatively correlate with the severity of arteriolar vasculopathy.

KW - Journal Article

U2 - 10.1681/ASN.2017040436

DO - 10.1681/ASN.2017040436

M3 - SCORING: Journal article

C2 - 29046343

JO - J AM SOC NEPHROL

JF - J AM SOC NEPHROL

SN - 1046-6673

ER -